Hussman Strategic Advisors, Inc. Harrow Health, Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $384 Million
- Q1 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 21,000 shares of HROW stock, worth $585,270. This represents 0.15% of its overall portfolio holdings.
Number of Shares
21,000Holding current value
$585,270% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
175Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$110 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$59.9 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$52.7 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$52 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$26.7 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $754M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...